HYBRID PEPTIDES: A NOVEL THERAPEUTIC FRONTIER

Chimera sequences represent a increasingly progressing domain in medicinal exploration, providing a unique strategy to target previously difficult conditions. These kind of designed structures integrate various peptide motifs, enabling for improved selectivity to diverse receptors and potentially